David B. Jaroch, PhD.

Senior Principal Scientist
Trisalus Life Sciences

Presentation(s):

• Pancreatic Retrograde Venous Infusion (PRVI) Significantly Enhances Delivery of NearIR Labelled SD-101 TLR9 Agonist to Targeted Regions of the Porcine Pancreas.

  Wednesday, March 8, 2023
  3:36 PM – 3:45 PM

  Disclosure(s): TriSalus Life Sciences: Intellectual Property Rights (Ongoing), Ownership Interest (Ongoing), Salaried Employee (Ongoing)